RSA Viewpoints

Brexit’s Uncertainty Principle

While the minutiae of the possible upcoming permutations for drug supply depending on various Brexit outcomes have been written about elsewhere, less thought has been...

Outlook: Medtech 2030

Having travelled in Europe in the last few weeks meeting clients and candidates, I wanted to share some reflections with you linked to one...

Where are all the medtech medics?

For many years now there has been a clear path for medical professionals who move from education to working in the pharmaceutical industry, both...

Lateral thinking for oncology leadership

The rapid growth in immuno-oncology therapeutics is causing talent headaches for the pharma industry Patients are already benefitting from pharma’s success in developing new...